{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:36:13Z","timestamp":1762648573059,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T00:00:00Z","timestamp":1677369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iLIVER"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.iliver.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T14:41:26Z","timestamp":1678027286000},"page":"67-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical characteristics of hepatopulmonary syndrome and hepatorenal syndrome and associated therapeutic potential of transjugular intrahepatic portosystemic shunt"],"prefix":"10.1016","volume":"2","author":[{"given":"Haoyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1972-7712","authenticated-orcid":false,"given":"Fuquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-017-0966-6","article-title":"Advances and challenges in cirrhosis and portal hypertension","volume":"15","author":"Berzigotti","year":"2017","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.iliver.2023.02.001_bib3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1185\/03007995.2015.1021905","article-title":"Presentation and complications associated with cirrhosis of the liver","volume":"31","author":"Poordad","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib4","first-page":"52","article-title":"Whole-course management of interventional treatment in liver cancer patients with portal hypertension","volume":"2","author":"Qiu","year":"2019","journal-title":"J Interv Cardiol"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/gastro\/gox009","article-title":"Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome","volume":"5","author":"Bucsics","year":"2017","journal-title":"Gastroenterology report"},{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"998","key":"10.1016\/j.iliver.2023.02.001_bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.2006.107789","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"84","author":"Salerno","year":"2008","journal-title":"Postgrad Med"},{"key":"10.1016\/j.iliver.2023.02.001_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.07.008","article-title":"An integrated review of the hepatorenal syndrome","volume":"22","author":"Ojeda-Yuren","year":"2021","journal-title":"Ann Hepatol"},{"issue":"45","key":"10.1016\/j.iliver.2023.02.001_bib9","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.3748\/wjg.v26.i45.7088","article-title":"Chinese guidelines on the management of liver cirrhosis (abbreviated version)","volume":"26","author":"Xu","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Mart\u00edn-Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.iliver.2023.02.001_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.iliver.2023.02.001_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.iliver.2023.02.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.mpmed.2019.07.001","article-title":"Renal dysfunction in liver disease","volume":"47","author":"Michael","year":"2019","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.iliver.2023.02.001_bib14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000492587","article-title":"Renal failure in patients with liver cirrhosis: novel classifications, biomarkers, treatment","volume":"34","author":"Appenrodt","year":"2018","journal-title":"Visceral medicine"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2017.05.041","article-title":"New developments in hepatorenal syndrome","volume":"16","author":"Mindikoglu","year":"2018","journal-title":"Clin Gastroenterol Hepatol : the official clinical practice journal of the American Gastroenterological Association"},{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.46.1.1","article-title":"Hepatopulmonary syndromes","volume":"46","author":"Krowka","year":"2000","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.iliver.2023.02.001_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jhep.2006.07.002","article-title":"The hepatopulmonary syndrome","volume":"45","author":"Palma","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.iliver.2023.02.001_bib18","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3748\/wjg.v20.i10.2586","article-title":"Cirrhosis and hepatopulmonary syndrome","volume":"20","author":"Tumgor","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.iliver.2023.02.001_bib19","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/liv.12791","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of\u00a0clinical assessment","volume":"35","author":"Raevens","year":"2015","journal-title":"Liver Int: Official Journal of the International Association\u00a0for\u00a0the Study of the Liver"},{"issue":"5","key":"10.1016\/j.iliver.2023.02.001_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary-hepatic vascular disorders (PHD)","volume":"24","author":"Rodr\u00edguez-Roisin","year":"2004","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.iliver.2023.02.001_bib21","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/liv.13741","article-title":"Pulmonary transit time derived from pulmonary angiography for the diagnosis of hepatopulmonary syndrome","volume":"38","author":"Zhao","year":"2018","journal-title":"Liver Int : official journal of the International Association for the Study of the Liver"},{"issue":"5","key":"10.1016\/j.iliver.2023.02.001_bib22","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/liv.12579","article-title":"Role of angiogenic factors\/cell adhesion markers in serum of cirrhotic patients with hepatopulmonary syndrome","volume":"35","author":"Raevens","year":"2015","journal-title":"Liver Int : official journal of the International Association for the Study of the Liver"},{"issue":"6","key":"10.1016\/j.iliver.2023.02.001_bib23","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/ajt.12713","article-title":"Prevalence and severity of hepatopulmonary syndrome and its influence on survival in cirrhotic patients evaluated for liver transplantation","volume":"14","author":"Pascasio","year":"2014","journal-title":"Am J Transplant: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"6","key":"10.1016\/j.iliver.2023.02.001_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/CS20140622","article-title":"Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung","volume":"129","author":"Chang","year":"2015","journal-title":"Clin Sci (London, England : 1979)"},{"issue":"8","key":"10.1016\/j.iliver.2023.02.001_bib25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.2016.20899","article-title":"Transjugular intrahepatic portosystemic shunts","volume":"317","author":"Sankar","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11739-019-02252-8","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes","volume":"15","author":"Vizzutti","year":"2020","journal-title":"Int Emerg Med"},{"issue":"4","key":"10.1016\/j.iliver.2023.02.001_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0168-8278(01)00309-9","article-title":"MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt","volume":"36","author":"Salerno","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.iliver.2023.02.001_bib28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.46.4.527","article-title":"Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure","volume":"46","author":"Jalan","year":"2000","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cgh.2015.06.042","article-title":"Association between transjugular intrahepatic portosystemic shunt and survival in patients with cirrhosis","volume":"14","author":"Berry","year":"2016","journal-title":"Clin Gastroenterol Hepatol : the official clinical practice journal of the American Gastroenterological\u00a0Association"},{"issue":"9","key":"10.1016\/j.iliver.2023.02.001_bib30","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1478-3231.2011.02498.x","article-title":"Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature","volume":"31","author":"Dasarathy","year":"2011","journal-title":"Liver Int : Official Journal of the International Association for the Study of the Liver"},{"issue":"7","key":"10.1016\/j.iliver.2023.02.001_bib31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00004836-200408000-00010","article-title":"Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts: role of increased pulmonary artery pressure","volume":"38","author":"Schwartz","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib32","article-title":"Hemodynamic evaluation of the right heart-pulmonary circulation unit in patients candidate to transjugular intrahepatic portosystemic shunt","volume":"11","author":"Manguso","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.iliver.2023.02.001_bib37","article-title":"TIPS is associated with lower in-hospital mortality for patients treated for hepatorenal syndrome (HRS) and refractory ascites:769","volume":"111","author":"Prabin","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.iliver.2023.02.001_bib38","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1007\/s10620-020-06136-2","article-title":"Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients","volume":"65","author":"Charilaou","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2008-1040323","article-title":"Pathogenesis and treatment of hepatorenal syndrome","volume":"28","author":"Arroyo","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.iliver.2023.02.001_bib40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.iliver.2023.02.001_bib41","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.iliver.2023.02.001_bib42","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.jhep.2008.01.010","article-title":"Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis","author":"Angeli","year":"2008","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.iliver.2023.02.001_bib44","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00134-019-05721-y","article-title":"Pulmonary complications in liver disease","volume":"45","author":"Bauer","year":"2019","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.iliver.2023.02.001_bib45","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.iliver.2023.02.001_bib46","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.26070","article-title":"Hepatopulmonary syndrome: favorable outcomes in the MELD exception era","volume":"57","author":"Iyer","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jhep.2013.03.026","article-title":"Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward","volume":"59","author":"Krowka","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.iliver.2023.02.001_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1155\/2010\/349076","article-title":"The role of garlic in hepatopulmonary syndrome: a randomized controlled trial","volume":"24","author":"De","year":"2010","journal-title":"Canadian journal of gastroenterology = Journal Canadien de Gastroenterologie"},{"issue":"3","key":"10.1016\/j.iliver.2023.02.001_bib49","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0016-5085(95)90409-3","article-title":"Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome","volume":"109","author":"Riegler","year":"1995","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.iliver.2023.02.001_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9270(02)05048-7","article-title":"TIPS: a treatment for refractory hypoxemia in a young patient with hepatopulmonary syndrome","volume":"97","author":"Attar","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.iliver.2023.02.001_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1572-0241.1998.00455.x","article-title":"Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome","volume":"93","author":"Selim","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.iliver.2023.02.001_bib52","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jvir.2015.04.017","article-title":"Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome: a systemic literature review","volume":"26","author":"Tsauo","year":"2015","journal-title":"J\u00a0Vasc Intervent Radiol : JVIR."},{"issue":"6","key":"10.1016\/j.iliver.2023.02.001_bib53","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1007\/s00330-018-5840-1","article-title":"Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome","volume":"29","author":"Tsauo","year":"2019","journal-title":"Eur Radiol"},{"issue":"43","key":"10.1016\/j.iliver.2023.02.001_bib54","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.3748\/wjg.v11.i43.6858","article-title":"Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome","volume":"11","author":"Martinez-Palli","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"49","key":"10.1016\/j.iliver.2023.02.001_bib55","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009080","article-title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome","volume":"96","author":"Zhao","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.iliver.2023.02.001_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1665-2681(19)31816-2","article-title":"Successful treatment of severe hepatopulmonary syndrome with a sequential use of TIPS placement and liver transplantation","volume":"8","author":"Ben\u00edtez","year":"2009","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jvir.2018.09.017","article-title":"Effect of transjugular intrahepatic portosystemic shunt creation on pulmonary gas exchange in patients with hepatopulmonary syndrome: a prospective study","volume":"30","author":"Tsauo","year":"2019","journal-title":"J\u00a0Vasc Intervent Radiol : JVIR."},{"issue":"11","key":"10.1016\/j.iliver.2023.02.001_bib58","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/liv.13893","article-title":"Hepatorenal syndrome in the era of acute kidney injury","volume":"38","author":"Sol\u00e9","year":"2018","journal-title":"Liver Int: Official Journal of the International Association for the Study of the Liver"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/jlts.2001.21287","article-title":"Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary\u00a0syndrome","volume":"7","author":"Lasch","year":"2001","journal-title":"Liver transplantation: Official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"},{"issue":"2","key":"10.1016\/j.iliver.2023.02.001_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1034\/j.1399-3046.2003.00033.x","article-title":"Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature","volume":"7","author":"Paramesh","year":"2003","journal-title":"Pediatr Transplant"}],"container-title":["iLIVER"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947823000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947823000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:31:25Z","timestamp":1762648285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772947823000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2772947823000075"],"URL":"https:\/\/doi.org\/10.1016\/j.iliver.2023.02.001","relation":{},"ISSN":["2772-9478"],"issn-type":[{"type":"print","value":"2772-9478"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of hepatopulmonary syndrome and hepatorenal syndrome and associated therapeutic potential of transjugular intrahepatic portosystemic shunt","name":"articletitle","label":"Article Title"},{"value":"iLIVER","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iliver.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}]}}